Navigation Links
Kingfisher Healthcare Receives European CE Mark for Next Generation Wound Healing Device
Date:3/12/2008

Innovative Device Utilizes Revolutionary Electrotherapy to Improve Healing

of Chronic Wounds

ALBUQUERQUE, New Mexico, March 12 /PRNewswire/ -- Kingfisher Americas, a healthcare company focused on improving patient quality of life, today announced that its parent company, Belgium-based Kingfisher Healthcare, has received CE mark for its KFH Novo medical device, a breakthrough medical technology that enhances the healing of chronic wounds. KFH Novo is the latest addition to Kingfisher's line of safe, non-invasive energy therapies designed to treat patients suffering from a range of chronic conditions.

KFH Novo utilizes Kingfisher's revolutionary Bio-Electric Stimulation Therapy (BEST) to assist in and improve upon the healing of chronic wounds including venous leg ulcers, diabetic ulcers and pressure sores. This unique form of electrotherapy enhances the physiological processes of wound healing at a cellular level, increasing protein synthesis levels, stimulating angiogenesis and fibroblasts, and increasing levels of ATP production to restart and regenerate tissue healing.

"Treatments for chronic wounds remain a major clinical challenge as a significant number of patients endure painful, open abrasions for as long as a year," said Dr. Henk Snyman, founder and CEO of Kingfisher Healthcare. "We are thrilled to offer physicians and patients a safe, non-invasive and cost-effective therapy designed to successfully treat several types of chronic wounds."

Designed for home use, KFH Novo is portable, convenient and easy-to-use. Its sleek and modern design elements, including patented touch-screen panel, allows patients to monitor and control their treatments. KFH Novo is expected to enter the U.S. market in 2009.

"We are pleased to announce the addition of KFH Novo to our line of innovative, alternative therapies," said Herb Whitaker, CEO of Kingfisher Americas. "We look forward to working with the European medical community to introduce this unique therapy intended to significantly improve upon each patient's quality of life."

For more information on KFH Novo please visit http://www.kfhealth.com.

About Kingfisher Americas

Kingfisher Americas, a subsidiary of the Belgium-based Kingfisher Healthcare, is the first company to use safe, non-invasive energy to treat patients suffering from chronic conditions. It utilizes a technology platform called BEST (Bio-Electric Stimulation Therapy) from which unique products are developed by Kingfisher Healthcare. Headquartered in Albuquerque, New Mexico, Kingfisher Americas focuses on establishing relationships with patients, patient support groups, and medical experts to improve the quality of life of fibromyalgia, post polio, and chronic fatigue syndrome patients. For more information, please visit http://www.kfamericas.com.


'/>"/>
SOURCE Kingfisher Americas
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Kingfisher Healthcare Launches Breakthrough Product in Europe
2. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
3. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
6. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
7. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
8. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
9. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
10. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
11. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... NEW YORK , March 24, 2017 ... Composite ended the trading session at 5,817.69, down 0.07%; ... finish at 20,656.58; and the S&P 500 closed at ... session as 4 sectors closed in green, 4 sectors ... the day. This Friday, Stock-Callers.com has initiated reports coverage ...
(Date:3/23/2017)... Research and Markets has announced the ... to their offering. ... The Global Market for Bioproducts Should Reach ... a CAGR of 8.9%, This research report ... seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and ...
(Date:3/23/2017)... CT (PRWEB) , ... March 23, 2017 , ... ... LLC, was recently selected by the Connecticut Technology Council (CTC) as a 2017 ... at CTC’s thirteenth annual Women of Innovation Awards Dinner. , The dinner recognizes ...
(Date:3/23/2017)... 2017 In today,s pre-market research, ... the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate ... SYN), and Regulus Therapeutics Inc. (NASDAQ: RGLS ... Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn ... at: ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Summary ... to better understand Merck KGaA and its partnering interests ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and ... the partnering activity of one of the world,s leading ... are prepared upon purchase to ensure inclusion of the ...
(Date:2/28/2017)... Germany , February 28, 2017 News ... ... Amsterdam from 14 to 16 March, Materna ... destination, and show how seamless travel is a real benefit for ... has added biometrics to their passenger touch point solutions to take ...
(Date:2/22/2017)... , Feb. 22, 2017 With the ... ABI Research identifies four technologies that innovative and ... secure significant share in the changing competitive landscape: ... passive authentication.   "Companies can no ... to security," says Dimitrios Pavlakis , Industry ...
Breaking Biology News(10 mins):